Overview
Hideyuki Majima practices in Kagoshima, Japan. Majima is rated as an Experienced expert by MediFind in the treatment of Neuroblastoma. Their top areas of expertise are Melioidosis, MELAS Syndrome, Malaria, and Long Haul COVID.
Their clinical research consists of co-authoring 51 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Neuroblastoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- MelioidosisMajima isAdvanced. Learn about Melioidosis.
- Experienced
- Long Haul COVIDMajima isExperienced. Learn about Long Haul COVID.
- MalariaMajima isExperienced. Learn about Malaria.
- MELAS SyndromeMajima isExperienced. Learn about MELAS Syndrome.
- NecrosisMajima isExperienced. Learn about Necrosis.
- NeuroblastomaMajima isExperienced. Learn about Neuroblastoma.
- Stomach CancerMajima isExperienced. Learn about Stomach Cancer.